Evolving new therapies of autoimmune hepatitis
- 1 August 2002
- journal article
- review article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 6 (3) , 825-850
- https://doi.org/10.1016/s1089-3261(02)00029-6
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- INTRAVENOUS IMMUNOGLOBULIN IN AUTOIMMUNE AND INFLAMMATORY DERMATOSES: A Review of Proposed Mechanisms of Action and Therapeutic ApplicationsDermatologic Clinics, 2000
- Tacrolimus (FK 506)Annals of Allergy, Asthma & Immunology, 1999
- BasiliximabDrugs, 1999
- CD28-B7 T CELL COSTIMULATORY BLOCKADE BY CTLA4Ig IN THE RAT RENAL ALLOGRAFT MODEL1,2Transplantation, 1996
- Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential usesJournal of the American Academy of Dermatology, 1996
- A new immunosuppressant: tacrolimusPublished by Oxford University Press (OUP) ,1996
- DeflazacortDrugs, 1995
- INDUCTION IMMUNOSUPPRESSION WITH ANTILYMPHOCYTE GLOBULIN OR OKT3 IN CADAVER KIDNEY TRANSPLANTATIONTransplantation, 1994
- Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitisJournal of Hepatology, 1994
- d-Penicillamine therapy in patients with HBsAg-negative chronic active hepatitis and major prednisolone-induced adverse effectsJournal of Hepatology, 1990